Boule Diagnostics AB (BOUL.ST)
Boule Diagnostics AB operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Spånga, AB, SE. The stock last traded at $2.35, down 2.08% on the session, giving a market capitalisation of $91.3M. Its beta of 0.17 implies it has historically moved less than the broad market.
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.
Boule Diagnostics AB is most often compared with the following Healthcare names: